HTR1A and epilepsy: A recent review has brought together the newer mechanistic evidence, showing that 5HT1A may mediate a number of actions, which have antiepileptic effects, including increasing GABA activity and reducing inflammatory cytokines and those patients with epilepsy may have reduced PET ligand binding at 5 HT1A sites [136].